Filing Details

Accession Number:
0001209191-22-039690
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-06-28 19:46:04
Reporting Period:
2022-04-14
Accepted Time:
2022-06-28 19:46:04
Original Submission Date:
2022-04-18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590144 Pura Vida Investments, Llc 512 W 22Nd Street
7Th Floor
New York NY 10011
No No Yes No
1789193 Efrem Kamen C/O Pura Vida Investments, Llc
512 W 22Nd Street, 7Th Floor
New York NY 10011
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-14 30,790 $1.23 7,381,237 No 4 P Indirect By Pura Vida Master Fund, Ltd.
Common Stock Acquisiton 2022-04-14 92,370 $1.26 7,473,607 No 4 P Indirect By Pura Vida Master Fund, Ltd.
Common Stock Acquisiton 2022-04-14 19,210 $1.23 8,475,033 No 4 P Indirect By the Managed Accounts.
Common Stock Acquisiton 2022-04-14 57,630 $1.26 8,532,663 No 4 P Indirect By the Managed Accounts.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Pura Vida Master Fund, Ltd.
No 4 P Indirect By Pura Vida Master Fund, Ltd.
No 4 P Indirect By the Managed Accounts.
No 4 P Indirect By the Managed Accounts.
Footnotes
  1. Aggregate number of shares purchased on the same date at difference prices.
  2. Represents the weighted-average purchase price. The shares were purchased in multiple transactions at prices ranging from $1.19 to $1.27, inclusive, per share. Full information regarding the number of shares purchased at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer or any security holder, upon request.
  3. Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund") and certain separately managed accounts (the "Managed Accounts," and together with the Pura Vida Master Fund, collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
  4. By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
  5. Represents the weighted-average purchase price. The shares were purchased in multiple transactions at prices ranging from $1.235 to $1.305, inclusive, per share. Full information regarding the number of shares purchased at each price shall be provided to the Staff, Issuer or any security holder, upon request.